Literature DB >> 21084996

Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa.

Mweete D Nglazi1, Stephen D Lawn, Richard Kaplan, Katharina Kranzer, Catherine Orrell, Robin Wood, Linda-Gail Bekker.   

Abstract

OBJECTIVES: To assess sustainability of programmatic outcomes in a community-based antiretroviral therapy (ART) service in South Africa during 7 years of scale-up.
METHODS: Prospective cohort of treatment-naive patients aged ≥ 15 years enrolled between 2002 and 2008. Data were analyzed by calendar period of ART initiation using time-to-event analysis and logistic regression.
RESULTS: ART was initiated by 3162 patients (67% women; median age, 34 years) who were followed-up for a median of 2.4 years (interquartile range, 1.2-3.8). After 6 years, the cumulative probability of death and loss to follow-up (LTFU) was 37.4%. The probabilities of transfer-out to another ART service and of virological failure were 21.6% and 23.1%, respectively. Low mortality risk and excellent virological and immunological responses during the first year of ART were not associated with calendar period of ART initiation. In contrast, risk of LTFU and virological failure both increased between successive calendar periods in unadjusted and adjusted analyses. The number of patients per member of clinic staff increased markedly over time.
CONCLUSIONS: Successful early outcomes (low mortality and good immunological and virological responses) were sustained between sequential calendar periods during 7 years of scale-up. In contrast, the increasing cumulative probabilities of LTFU or virological failure may reflect decreasing capacity to adequately support patients during long-term therapy as clinic caseload escalated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21084996      PMCID: PMC3776048          DOI: 10.1097/QAI.0b013e3181ff0bdc

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  18 in total

1.  Promoting retention in care: an effective model in an antiretroviral treatment service in South Africa.

Authors:  Stephen D Lawn; Richard Kaplan; Robin Wood; Linda-Gail Bekker
Journal:  Clin Infect Dis       Date:  2007-09-15       Impact factor: 9.079

2.  Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

Authors:  Stephen D Lawn; Landon Myer; Guy Harling; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  Clin Infect Dis       Date:  2006-08-08       Impact factor: 9.079

3.  Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.

Authors:  Louise C Ivers; David Kendrick; Karen Doucette
Journal:  Clin Infect Dis       Date:  2005-05-27       Impact factor: 9.079

4.  Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.

Authors:  Andrew Boulle; Gilles Van Cutsem; Katherine Hilderbrand; Carol Cragg; Musaed Abrahams; Shaheed Mathee; Nathan Ford; Louise Knight; Meg Osler; Jonny Myers; Eric Goemaere; David Coetzee; Gary Maartens
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

5.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Authors:  Martin W G Brinkhof; François Dabis; Landon Myer; David R Bangsberg; Andrew Boulle; Denis Nash; Mauro Schechter; Christian Laurent; Olivia Keiser; Margaret May; Eduardo Sprinz; Matthias Egger; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

Review 6.  Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

7.  HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme.

Authors:  Catherine Orrell; Rochelle P Walensky; Elena Losina; Jennifer Pitt; Kenneth A Freedberg; Robin Wood
Journal:  Antivir Ther       Date:  2009

8.  Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Authors:  Stephen D Lawn; Landon Myer; David Edwards; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

9.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

Review 10.  Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox; Christopher J Gill
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  79 in total

1.  Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?

Authors:  Leigh F Johnson; Janne Estill; Olivia Keiser; Morna Cornell; Haroon Moolla; Michael Schomaker; Anna Grimsrud; Mary-Ann Davies; Andrew Boulle
Journal:  Am J Epidemiol       Date:  2014-11-15       Impact factor: 4.897

2.  Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.

Authors:  C William Wester; Ori M Stitelman; Victor deGruttola; Hermann Bussmann; Richard G Marlink; Mark J van der Laan
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

3.  Operational research training: the course and beyond.

Authors:  K Bissell; A D Harries; A J Reid; M Edginton; S G Hinderaker; S Satyanarayana; D A Enarson; R Zachariah
Journal:  Public Health Action       Date:  2012-09-21

4.  Outcomes of antiretroviral treatment programs in rural Southern Africa.

Authors:  Gilles Wandeler; Olivia Keiser; Karolin Pfeiffer; Sabrina Pestilli; Christiane Fritz; Niklaus D Labhardt; Franzisco Mbofana; Robert Mudyiradima; Jan Emmel; Matthias Egger; Jochen Ehmer
Journal:  J Acquir Immune Defic Syndr       Date:  2012-02-01       Impact factor: 3.731

Review 5.  Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013.

Authors:  Matthew P Fox; Sydney Rosen
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

6.  Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.

Authors:  Cynthia Riviere; Elizabeth Faust; Thane Miller; Eduard J Beck; Elaine Baruwa; Patrice Severe; Karine Severe; Claudia Thomas Riché; Rachelle Cassagnol; Sidney Atwood; Morgan Esperance; Lauren Webster; Pierre Cremieux; Jean W Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

7.  A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.

Authors: 
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-03       Impact factor: 2.205

8.  Long-term antiretroviral treatment outcomes in seven countries in the Caribbean.

Authors:  Serena P Koenig; Luis A Rodriguez; Courtenay Bartholomew; Alison Edwards; Tracie E Carmichael; Geoffrey Barrow; André Cabié; Robert Hunter; Giselle Vasquez-Mora; Avion Quava-Jones; Nicholas Adomakoh; J Peter Figueroa; Bernard Liautaud; Magaly Torres; Jean W Pape
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

9.  Trends in Causes of Adult Deaths among the Urban Poor: Evidence from Nairobi Urban Health and Demographic Surveillance System, 2003-2012.

Authors:  Blessing Mberu; Marylene Wamukoya; Samuel Oti; Catherine Kyobutungi
Journal:  J Urban Health       Date:  2015-06       Impact factor: 3.671

10.  Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.

Authors:  Edva Noel; Morgan Esperance; Megan McLaughlin; Rachel Bertrand; Jessy Devieux; Patrice Severe; Diessy Decome; Adias Marcelin; Janet Nicotera; Chris Delcher; Mark Griswold; Genevive Meredith; Jean William Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.